Sumbangan 15 September 2024 – 1 Oktober 2024 Tentang pengumpulan dana

Infection-enhancing anti-SARS-CoV-2 antibodies recognize...

Main
Infection-enhancing anti-SARS-CoV-2...

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

Nouara Yahi & Henri Chahinian & Jacques Fantini

0 / 0

Sukakah Anda buku ini?

Bagaimana kualitas file yang diunduh?

Unduh buku untuk menilai kualitasnya

Bagaimana kualitas file yang diunduh?

Journal of Infection, Corrected proof. doi:10.1016/j.jinf.2021.08.010

Tahun:

2021

Penerbit:

Elsevier Ltd

Bahasa:

english

File:

PDF, 591 KB

IPFS:

,

english, 2021

Membaca daring

Pengubahan menjadi sedang diproses

Pengubahan menjadi gagal

Mungkin Anda tertarik

William A. Haseltine — Variants! The Shape-Shifting Challenge of COVID-19

Dr. Sherri Tenpenny — 20 Mechanisms of Injuries - COVID19

Nature — The International Journal of Science : Covid Questions August 2020

unknown — Science

Spartacus — COVID-19 - The Spartacus Letter

Dr. Sherri Tenpenny — 20 Mechanisms of Injuries (MOI) - How COVID-19 Injections Can Make You Sick; Even Kill You

— A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model

Stephanie Seneff and Greg Nigh — Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19

Unknown — COVID-19: The Science We Should Know

Paul A. Offit — Tell Me When It's Over

Science Magazine — Science Magazine, 8 May 2020: Early Life Immunology Special Issue

Sherry Tenpenny — 20 Mechanisms of Injuries (MOI) How COVID-19 Injections Can Make You Sick...Even Kill You (Parts 1 + 2) (40 mechanisms)

Richard D. Hylton — A Closer Look at the Covid-19 Variants

wangke — SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Michael Palmer, Sucharit Bhakdi, Brian Hooker, Mary Holland, Margot DesBois, David Rasnick, Catherine Austin Fitts — mRNA Vaccine Toxicity

— A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19

— B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

— Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

— Evolution of antibody immunity to SARS-CoV-2

Dina S. Morris — The Status and Unchanging Names of the Corona Virus

Paul A. Offit, M.D. — Tell Me When It's Over: An Insider's Guide to Deciphering Covid Myths and Navigating Our Post-Pandemic World

Paul A. Offit, MD — Tell Me When It's Over

Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng — Progress and Prospects on Vaccine Development against SARS-CoV-2

Qiang Zhang, Huajun Zhang, Kun Huang, Yong Yang — SARS-CoV-2 neutralizing serum antibodies in cats: A serological investigation

Chek Meng Poh, Guillaume Carissimo, Bei Wang — Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein

Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi — COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Rui Chen, Jiayu Fu, Jingfei Hu, Cheng Li — Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus

Shibo Jiang, Christopher Hillyer, Lanying Du — Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Takahiko Koyama, Dilhan Weeraratne, Jane L. Snowdon, Laxmi Parida — Emergence of Drift Variants That May Affect COVID‐19 Vaccine Development and Antibody Treatment

Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Bert Schepens, Xavier Saelens, Jason S. McLellan — Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Cuiqing Ma, Ye Lia, Lili Wang, Guangyu Zhao, Xinrong Tao, Chien-Te K. Tseng, Yusen Zhou, Lanying Dua, Shibo Jianga — Intranasal vaccination with recombinant receptor-binding domain ofMERS-CoV spike protein induces much stronger local mucosalimmune responses than subcutaneous immunization: Implication fordesigning novel mucosal MERS vaccines

Frank J. Dixon — Advances in Immunology 77

John Rhodes — How to Make a Vaccine: An Essential Guide for COVID-19 and Beyond

John Rhodes — How to Make a Vaccine: An Essential Guide for COVID-19 and Beyond

Chakraborty, Arup K., Shaw, Andrey — Viruses, Pandemics, and Immunity

Istilah kunci